- Home
- Industry Reports
- Biotechnology
- Healthcare
- RNAi Technology Market – Size, Outlook, Trends and Forecast (2024 – 2032)
RNAi technology is a process which inhibits gene expression by neutralizing the targeted mRNA. In the fields of pharmaceutical and biotechnology, RNAi technology will help to improve technologies in therapeutics and drug discovery. RNAi is commonly known as co-suppression or quelling.
Global RNAi Technology Market Segments Size & Growth:
Global RNAi Technology Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by increasing research activities in RNAi technology mainly in cancer. However, reimbursement and FDA regulations hinder the growth of the global RNAi technology market.
Global RNAi Technology Market Segments Share:
Global RNAi Technology Market is categorized into by application which consists of agriculture, drug discovery, research & development, and therapeutics. Within the RNAi technology market, a therapeutic segment is further classified by oncology, heart ailment, neurodegenerative disease, respiratory disorders, autoimmune hepatitis, and metabolic disorders. Research and development have the largest share due to increase in research developments in RNAi technology mainly on chronic diseases, such as cancer.
On the basis of Geography, North America is dominating the global RNAi technology market and the growth in North America is mainly attributed because of huge investments in R&D activities and advancements in therapies. Furthermore, Asia-Pacific is witnessing the fastest growth during the forecast period, due to rapidly increasing pharmaceutical infrastructure and the government initiatives.
Global RNAi Technology Market Segments Trends:
- In recent research, Thermo Fisher Scientific Inc. has developed a new technology to reduce the gene function by mammalian gene expression.
- In August 2017, Thermo Fisher Scientific Inc. has acquired Patheon N.V. to expand services in pharmaceutical and biotechnology firms.
Global RNAi Technology Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Thermo Fisher Scientific Inc.
- Qiagen NV
- Alnylam Pharmaceuticals
- Merck & Co. Inc. (Sigma Aldrich)
- Quark Pharmaceuticals Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increasing research activities in RNAi technology mainly in cancer
4.2. Restraints
4.2.1 FDA regulations and reimbursement facilities
4.3 Opportunities
4.3.1 Rising demand for genetics-based on In-Vitro-Diagnostics
4.4 Challenges
4.4.1 Determining design for siRNA sequence and off-target effects.
Chapter 5 Global RNAi Technology Market – By Application
5.1 Agriculture
5.2 Research and development
5.3 Drug discovery
5.4 Therapeutics
5.4.1 Autoimmune Hepatitis
5.4.2 Ocular Disorders
5.4.3 Hepatitis B and C
5.4.4 Oncology
5.4.5 Respiratory Disorders
5.4.6 Heart ailments
5.4.7 Neurodegenerative disease
5.4.8 Others
Chapter 6 Global RNAi Technology Market – By Geography
6.1 Introduction
6.2 North America
6.2.1. The U.S.
6.2.2. Canada
6.2.3. Mexico
6.3 Europe
6.3.1. U.K.
6.3.2. Germany
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Rest of Europe
6.4 Asia Pacific
6.4.1. China
6.4.2. Japan
6.4.3. India
6.4.3. Australia & New Zealand
6.4.5. South Korea
6.4.6. Rest of APAC
6.5 South America
6.5.1. Brazil
6.5.2. Argentina
6.5.3. Others
6.6. Middle East & Africa
6.6.1. Middle East
6.6.2. Africa
Chapter 7 Global RNAi Technology Market – Company Profiles
7.1. Thermo Fisher Scientific Inc.
7.2. Qiagen NV
7.3. Alnylam Pharmaceuticals
7.4. Merck & Co. Inc. (Sigma Aldrich)
7.5. Quark Pharmaceuticals Inc.
7.6. Ionis Pharmaceuticals Inc.
7.7. Arcturus Therapeutics
7.8. Silence Therapeutics
7.9. Pfizer Inc.
7.10. Benitec Biopharma Ltd
7.11 Takara Bio Inc. (Clonetch)
7.12 Invitrogen.
7.13 F. Hoffmann-La Roche Ag (Roche)
Chapter 8 Global RNAi Technology Market – Competitive Landscape
8.1. Market Share Analysis
8.2. Strategies Adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,489.86 - €7,469.57
- INR: ₹225,053.86 - ₹675,161.59
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,133.43 - £6,400.30
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
RNAi technology is a process which inhibits gene expression by neutralizing the targeted mRNA. In the fields of pharmaceutical and biotechnology, RNAi technology will help to improve technologies in therapeutics and drug discovery. RNAi is commonly known as co-suppression or quelling.
Global RNAi Technology Market Segments Size & Growth:
Global RNAi Technology Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by increasing research activities in RNAi technology mainly in cancer. However, reimbursement and FDA regulations hinder the growth of the global RNAi technology market.
Global RNAi Technology Market Segments Share:
Global RNAi Technology Market is categorized into by application which consists of agriculture, drug discovery, research & development, and therapeutics. Within the RNAi technology market, a therapeutic segment is further classified by oncology, heart ailment, neurodegenerative disease, respiratory disorders, autoimmune hepatitis, and metabolic disorders. Research and development have the largest share due to increase in research developments in RNAi technology mainly on chronic diseases, such as cancer.
On the basis of Geography, North America is dominating the global RNAi technology market and the growth in North America is mainly attributed because of huge investments in R&D activities and advancements in therapies. Furthermore, Asia-Pacific is witnessing the fastest growth during the forecast period, due to rapidly increasing pharmaceutical infrastructure and the government initiatives.
Global RNAi Technology Market Segments Trends:
- In recent research, Thermo Fisher Scientific Inc. has developed a new technology to reduce the gene function by mammalian gene expression.
- In August 2017, Thermo Fisher Scientific Inc. has acquired Patheon N.V. to expand services in pharmaceutical and biotechnology firms.
Global RNAi Technology Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Thermo Fisher Scientific Inc.
- Qiagen NV
- Alnylam Pharmaceuticals
- Merck & Co. Inc. (Sigma Aldrich)
- Quark Pharmaceuticals Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increasing research activities in RNAi technology mainly in cancer
4.2. Restraints
4.2.1 FDA regulations and reimbursement facilities
4.3 Opportunities
4.3.1 Rising demand for genetics-based on In-Vitro-Diagnostics
4.4 Challenges
4.4.1 Determining design for siRNA sequence and off-target effects.
Chapter 5 Global RNAi Technology Market – By Application
5.1 Agriculture
5.2 Research and development
5.3 Drug discovery
5.4 Therapeutics
5.4.1 Autoimmune Hepatitis
5.4.2 Ocular Disorders
5.4.3 Hepatitis B and C
5.4.4 Oncology
5.4.5 Respiratory Disorders
5.4.6 Heart ailments
5.4.7 Neurodegenerative disease
5.4.8 Others
Chapter 6 Global RNAi Technology Market – By Geography
6.1 Introduction
6.2 North America
6.2.1. The U.S.
6.2.2. Canada
6.2.3. Mexico
6.3 Europe
6.3.1. U.K.
6.3.2. Germany
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Rest of Europe
6.4 Asia Pacific
6.4.1. China
6.4.2. Japan
6.4.3. India
6.4.3. Australia & New Zealand
6.4.5. South Korea
6.4.6. Rest of APAC
6.5 South America
6.5.1. Brazil
6.5.2. Argentina
6.5.3. Others
6.6. Middle East & Africa
6.6.1. Middle East
6.6.2. Africa
Chapter 7 Global RNAi Technology Market – Company Profiles
7.1. Thermo Fisher Scientific Inc.
7.2. Qiagen NV
7.3. Alnylam Pharmaceuticals
7.4. Merck & Co. Inc. (Sigma Aldrich)
7.5. Quark Pharmaceuticals Inc.
7.6. Ionis Pharmaceuticals Inc.
7.7. Arcturus Therapeutics
7.8. Silence Therapeutics
7.9. Pfizer Inc.
7.10. Benitec Biopharma Ltd
7.11 Takara Bio Inc. (Clonetch)
7.12 Invitrogen.
7.13 F. Hoffmann-La Roche Ag (Roche)
Chapter 8 Global RNAi Technology Market – Competitive Landscape
8.1. Market Share Analysis
8.2. Strategies Adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.